Theranica
PrivateLast Round
Series D
Dec 23, 2025
Total Funding Raised
$116M
Company Overview
Theranica operates in Healthcare & Life Sciences and is based in Netanya. Its latest recorded funding round was a Series D round in December 2025.
Theranica is a digital therapeutics company that develops Nerivio, an FDA-cleared, prescribed wearable device for the acute and preventive treatment of migraine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theranica Comparables
Compare Theranica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurolief | 88% | |
| eNeura | 86% | |
| electroCore | 79% |
For institutional investors. Book with your work email.
Theranica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 23, 2025 | ||||
| Series C | Aug 29, 2022 | ||||
| Series B | Mar 18, 2019 | ||||
| Series A | Jul 3, 2017 | ||||
| Seed | Sep 21, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Theranica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Corundum Open Innovation | Series C, Series A, Series B |
| New Rhein Healthcare Investors | Series C |
| aMoon | Series C, Series B |
| Omron Ventures | Series B |
| Takoa Invest | Series C, Series B |
| LionBird | Series C, Series A, Series B |
| Infinity Medical | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
Actively selling into Veterans Affairs, Department of Defense, and Indian Health Services.
- Oct 8, 2025
Attended CNS 2025 to share evidence on migraine interventions.
For institutional investors. Book with your work email.
Theranica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Theranica's valuation, stock price, and market status.
Is Theranica a public or private company?
Theranica is a private company.
What is the current stock price of Theranica?
Theranica is a private company, so its shares have no public market price. Caplight tracks Theranica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theranica worth (valuation)?
Valuation information for Theranica is not publicly available.
Can I buy Theranica stock?
Theranica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theranica's last funding round?
Theranica's most recent funding round was Series D on December 23, 2025.
Who are the main investors in Theranica?
Key investors in Theranica include New Rhein Healthcare Investors, aMoon, Lightspeed Venture Partners.
Will Theranica IPO soon?
No public IPO plans have been announced for Theranica.
How can I track Theranica secondary market activity?
Caplight tracks bids, offers, and trades in Theranica's shares on secondary markets.